QIAGEN N.V. stock analysis

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technolo

Ticker: QGEN
Exchange: NYSE
Sector: Health Care
Industry: Health Care Equipment & Services

Market evidence and data freshness

The public preview recorded QIAGEN N.V. at 50.735 USD on 2026-11-05T18:32:07.000Z and marked the quote as delayed. This observation is not a trading signal.

Available price history spans 2021-11-03 through 2026-10-23 across 1248 observations; the listed source is CommonQuant Parquet archive backed by Yahoo Finance delayed data. The history end date differs from the latest quote date.

What should I review before buying QIAGEN N.V. stock?

Compare valuation with reported financial performance, inspect the price history, and weigh the evidence for and against the investment case. Review the risks and assumptions before making your own decision.

Inside the full analysis

Valuation
Growth
Financial health
Ownership
Research

Sign in to open the full analysis. Paid plans use included reports first, then your weekly usage limit. Access lasts 72 hours, including revisits.